Related references
Note: Only part of the references are listed.Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce a-Fetoprotein
Vatche G. Agopian et al.
JAMA SURGERY (2017)
Promise and Pitfalls of Using a-Fetoprotein in Liver Transplantation Allocation for Hepatocellular Carcinoma
Barry Schlansky et al.
JAMA SURGERY (2017)
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution
Quirino Lai et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium
Vatche G. Agopian et al.
ANNALS OF SURGERY (2017)
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
Vincenzo Mazzaferro
HEPATOLOGY (2016)
Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy - Implications for transplant eligibility
Timothy M. Pawlik et al.
ANNALS OF SURGERY (2007)
Alphafetoprotein: an obituary
M Sherman
JOURNAL OF HEPATOLOGY (2001)
Share Paper
